- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Bioceres Crop Solutions Corp(BIOX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BIOX
09/28/2026: BIOX (1-star) is currently NOT-A-BUY. Pass it for now.
Bioceres Crop Solutions Corp is a specialized agricultural biotechnology company known for its proprietary HB4 drought-tolerant trait technology and biological crop solutions. The company holds a distinct position by focusing on high-growth, sustainable farming innovations that aim to increase productivity in changing climates. Its main growth story is centered on the ongoing global commercialization of its HB4 traits and the expansion of its biological product sales. Investors face notable risks, however, including high geographic concentration, significant regulatory hurdles, and intense competition from large-cap agricultural giants. The stock likely suits growth-oriented investors with a high tolerance for risk and a long-term horizon for market adoption.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company offers exposure to high-growth areas of agricultural technology and biotechnology innovation. |
| Momentum investor | Mixed fit | Momentum fit is conditional on a sustained positive upturn signal and successful commercial milestones for HB4. |
| Value investor | Weak fit | The stock often trades based on future growth expectations rather than current earnings or book value. |
| Dividend investor | Weak fit | The company does not pay a dividend and is currently focused on capital-intensive growth. |
| Low-risk investor | Weak fit | High volatility and regulatory risks inherent in ag-tech make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to significant price swings due to its growth profile and sensitivity to market sentiment. |
| Valuation risk | Medium / high | Future growth is heavily priced in, and valuation may compress if commercial milestones are not met. |
| Competition risk (Ag-tech giants) | High | Large-cap competitors have greater resources to defend their market share and develop competing traits. |
| Business quality | Medium | While the technology is innovative, the company is still establishing consistent long-term profitability. |
| Dividend income | Low / none | Investors should expect no income and must rely entirely on capital appreciation. |
| Execution risk | Medium / high | Successfully scaling international regulatory approvals and commercial adoption is complex and uncertain. |
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -38.98% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 23.89M USD | Price to earnings Ratio - | 1Y Target Price 2 |
Price to earnings Ratio - | 1Y Target Price 2 | ||
Volume (30-day avg) 447.5K shares | Beta 0.43 | 52 Weeks Range 0.30 - 2.19 | Updated Date 09/28/2026 |
52 Weeks Range 0.30 - 2.19 | Updated Date 09/28/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.74 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Seed and Integrated Products | Licensing of HB4 traits and sale of integrated seed solutions. | This is the 'high-tech' core of the business, where the potential for recurring licensing revenue lies. |
| Crop Protection/Biologicals | Sales of bio-stimulants, fertilizers, and crop protection chemicals. | This provides the company with more stable, recurring cash flow compared to its R&D-heavy segments. |
| Geography (Latin America) | Primary sales and commercial operations in Argentina, Brazil, and surrounding regions. | Regional focus means the company is heavily influenced by local economic and climate conditions. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 14.99 | Enterprise Value 249.62M | Price to Sales(TTM) 0.1 |
Enterprise Value 249.62M | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA 17.98 | Shares Outstanding 63.82M | Shares Floating 45.01M |
Shares Outstanding 63.82M | Shares Floating 45.01M | ||
Percent Insiders 16.95 | Percent Institutions 23.13 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Bioceres Crop Solutions Corp
Exchange NASDAQ | Headquarters - | ||
IPO Launch date 2018-03-22 | CEO & Executive Director Dr. Federico Trucco Ph.D. | ||
Sector Basic Materials | Industry Agricultural Inputs | Full time employees 751 | |
Full time employees 751 | |||
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

